SEC Form EFFECT filed by Omega Therapeutics Inc.

3/26/25 12:15:12 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Notice of Effectiveness

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 25, 2025

Accession Number:

0001193125-25-060215

Submission Type:

POS AM

Date	Price Target	Rating	Analyst
11/15/2024		Outperform → Mkt Perform	Raymond James
6/18/2024	$12.00	Outperform	Raymond James
5/25/2023	$18.00 → $15.00	Buy	Jefferies
12/8/2022	$11.00	Buy	H.C. Wainwright
9/23/2022	$12.00	Buy	Chardan Capital Markets
8/24/2021	$36.00	Outperform	Wedbush
8/24/2021	$30.00	Buy	Jefferies
8/24/2021	$30.00	Overweight	Piper Sandler

Recent Analyst Ratings for
$OMGA